Chronic Exposure to Nanoplastics: A New Cardiovascular Risk Factor

Recent research has highlighted the potential cardiovascular risks associated with chronic exposure to polystyrene nanoplastics, particularly their impact on lipid metabolism and gut health. In a study involving LDLr-/- mice subjected to 12 weeks of oral exposure to 80 nm nanoplastics, significant increases in aortic lipid deposition were observed. This indicates that nanoplastics may play a role in the pathogenesis of atherosclerosis, a major contributor to cardiovascular disease. The study utilized a multi-omics approach, integrating aortic plaque quantification, hepatic transcriptomics, gut microbiome sequencing, and liver metabolomics. Findings revealed that nanoplastic exposure not only exacerbated lipid accumulation in the aorta but also suppressed hepatic detoxification pathways. This suppression was linked to alternative splicing events in gene expression, which altered the production of proteins involved in lipid metabolism and detoxification processes. Moreover, the gut microbiome analysis showed a marked dysbiosis, characterized by a reduction in short-chain fatty acid (SCFA)-producing bacteria and an increase in pro-atherogenic pathobionts. These changes in gut microbiota were associated with specific hepatic functional impairments, suggesting a gut-liver axis that could be disrupted by environmental pollutants like nanoplastics. Metabolomic profiling indicated decreased levels of critical metabolites such as gamma-glutamylcysteine, a precursor for the antioxidant glutathione, and neurine, derived from choline. These alterations suggest a heightened state of oxidative stress and potential involvement of trimethylamine N-oxide (TMAO) pathways, which are known to influence cardiovascular health. This research underscores the importance of considering environmental factors, such as nanoplastics, in the context of metabolic health. The findings suggest that chronic exposure to these materials could serve as an early warning biomarker for cardiovascular disease, highlighting the need for further investigation into their long-term effects on human health.